Primary and Secondary Stroke Prevention

Contributing journals to this collection:
Hypertension, Circulation: Heart Failure, Stroke, Circulation Research, Circulation: Arrhythmia and Electrophysiology, Circulation: Cardiovascular Genetics, Arteriosclerosis, Thrombosis, and Vascular Biology, Circulation: Cardiovascular Outcomes and Quality, Circulation, Circulation: Cardiovascular Interventions, and Circulation: Cardiovascular Imaging

Citations 1-10 of 408 total displayed.

Most recent content

Original Articles
Epidemiology of Subtherapeutic Anticoagulation in the United States

Adam J. Rose, Al Ozonoff, Richard W. Grant, Lori E. Henault, and Elaine M. Hylek
Circ Cardiovasc Qual Outcomes 2009;2:591-597; published online before print as doi:10.1161/CIRCOUTCOMES.109.862763 [Abstract] [Full text]  

Original Contributions
Carotid Artery Imaging for Secondary Stroke Prevention: Both Imaging Modality and Rapid Access to Imaging Are Important

Joanna M. Wardlaw, Matt D. Stevenson, Francesca Chappell, Peter M. Rothwell, Jonathan Gillard, Gavin Young, Steven M. Thomas, Giles Roditi, and Michael J. Gough
Stroke 2009;40:3511-3517; published online before print as doi:10.1161/STROKEAHA.109.557017 [Abstract] [Full text]  

Past content

Original Contributions
High-Sensitivity C-Reactive Protein and Lipoprotein-Associated Phospholipase A₂ Stability Before and After Stroke and Myocardial Infarction

Mitchell S.V. Elkind, Vladimir Leon, Yeseon P. Moon, Myunghee C. Paik, and Ralph L. Sacco
Stroke 2009;40:3233-3237; published online before print as doi:10.1161/STROKEAHA.109.552802 [Abstract] [Full text]  

Articles
Carotid Artery Imaging for Secondary Stroke Prevention. Both Imaging Modality and Rapid Access to Imaging Are Important

Joanna M. Wardlaw, Matt D. Stevenson, Francesca Chappell, Peter M. Rothwell, Jonathan Gillard, Gavin Young, Steven M. Thomas, Giles Roditi, and Michael J. Gough
Stroke published September 3, 2009, doi:10.1161/STROKEAHA.109.557017 [Abstract]  

Controversies in Stroke
Angiotensin Receptor Blockers Should Be Regarded as First-Line Drugs for Stroke Prevention in Both Primary and Secondary Prevention Settings: Yes

Daniel G. Hackam
Stroke 2009;40:3159-3160; published online before print as doi:10.1161/STROKEAHA.109.559054 [Full text]  

Articles
Angiotensin Receptor Blockers Should Be Regarded as First-Line Drugs for Stroke Prevention in Both Primary and Secondary Prevention Settings. Yes

Daniel G. Hackam
Stroke published July 30, 2009, doi:10.1161/STROKEAHA.109.559054 [Abstract]  

Articles
High-Sensitivity C-Reactive Protein and Lipoprotein-Associated Phospholipase A₂ Stability Before and After Stroke and Myocardial Infarction

Mitchell S.V. Elkind, Vladimir Leon, Yeseon P. Moon, Myunghee C. Paik, and Ralph L. Sacco
Stroke published July 30, 2009, doi:10.1161/STROKEAHA.109.552802 [Abstract]  

AHA Policy Statement
Recommendations for the Implementation of Telemedicine Within Stroke Systems of Care: A Policy Statement From the American Heart Association

Lee H. Schwamm, Heinrich J. Audebert, Pierre Amarenco, Neale R. Chumbler, Michael R. Frankel, Mary G. George, Philip B. Gorelick, Katie B. Horton, Markku Kaste, Daniel T. Lackland, Steven R. Levine, Brett C. Meyer, Philip M. Meyers, Victor Patterson, Steven K. Stranne, Christopher J. White on behalf of the American Heart Association Stroke Council; Council on Epidemiology and Prevention; Interdisciplinary Council on Peripheral Vascular Disease; and the Council on Cardiovascular Radiology and Intervention
Stroke 2009;40:2635-2660; published online before print as doi:10.1161/STROKEAHA.109.192361 [Full text]  

AHA/ASA/ACCF Science Advisory
Percutaneous Device Closure of Patent Foramen Ovale for Secondary Stroke Prevention: A Call for Completion of Randomized Clinical Trials: A Science Advisory From the American Heart Association/American Stroke Association and the American College of Cardiology Foundation The American Academy of Neurology affirms the value of this science advisory.

Patrick T. O'Gara, Steven R. Messe, E. Murat Tuzcu, Gloria Catha, and John C. Ring
Circulation 2009;119:2743-2747; published online before print as doi:10.1161/CIRCULATIONAHA.109.192272 [Abstract] [Full text]  

Articles
Percutaneous Device Closure of Patent Foramen Ovale for Secondary Stroke Prevention. A Call for Completion of Randomized Clinical Trials, A Science Advisory From the American Heart Association/American Stroke Association and the American College of Cardiology Foundation

Patrick T. O'Gara, Steven R. Messe, E. Murat Tuzcu, Gloria Catha, and John C. Ring
Circulation published May 11, 2009, doi:10.1161/CIRCULATIONAHA.109.192272 [Abstract]  

[Next page] Pages: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41